Nasdaq July 9, 2021

By Panna Sharma, President & CEO, Lantern Pharma, Inc. (LTRN)

The world of big data in the healthcare sector is vast and growing exponentially. Tools that leverage artificial intelligence (AI) and machine learning (ML) are critical to organizing, correlating, making sense of and generating useful discoveries from this avalanche of healthcare and medical data. Analysts suggest that 30% of the world’s data now comes from healthcare and is growing faster than any other industry with a CAGR (compound annual growth rate) of 36%. In genomics and biomarker driven drug development the growth rate of data is even higher, with analysts suggesting that it is doubling every 24 months.

To take full advantage of this data and develop powerful insights and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Big Data, Technology
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Alphabet shares jump 14% on earnings beat, first-ever dividend
Microsoft: Unlocking AI Benefits Will Require Cultural Changes for Enterprises
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.

Share This Article